Connect with us
Cardiol Therapeutics is rapidly advancing toward gaining FDA approval for its breakthrough heart treatment for multiple cardiovascular diseases — CardiolRx™. The company is leveraging FDA and...
Boehringer Ingelheim has developed this new obesity drug with Zealand Pharma. Survodutide works by mimicking a gut hormone called glucagon-like peptide-1, which suppresses appetite and helps...
Ipsen markets more than twenty medicines in more than 115 countries and has a direct commercial presence in more than 30 states. Ipsen's research and development...
Gilead said that it expects the agreement with Tentarix to reduce its earnings per share (EPS) from 3 to 4 cents in 2023. In addition, the...
Currently, the British multinational does not have any project related to this type of therapy. AstraZeneca tried to reach this market through a negotiation with Moderna, but...
Neuralink, Elon Musk's brain-computer interface startup, has just raised $280 million for its brain implant technology. Initially, Neuralink aims to treat Alzheimer's and paralysis. It will...
Roche recently partnered with Alnylam for the development and commercialization of a treatment for hypertension in patients with high cardiovascular risk. The Swiss company makes an initial...
Doctomatic uses artificial intelligence capable of reading data from images to find out if a person may or may not have a disease. The company's clients...
In 2023, Bayer hoped to have a sales volume of between €51 billion and €52 billion, which is now reduced to between €48.5 billion and €49.5 billion,...
Novartis is aiming for its annual sales to grow in the high single digits this year when it previously estimated they would grow in the mid-single...
 |
|
 |  |
 |
|